Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

Chemotherapy-induced thrombocytopenia (CIT) is a potentially serious complication that can lead to chemotherapy dose delays, dose reductions, or discontinuation, and increases the risk of serious bleeding even...

Source: BMC Cancer - February 14, 2019 Category: Cancer & Oncology Authors: Derek Weycker, Mark Hatfield, Aaron Grossman, Ahuva Hanau, Alex Lonshteyn, Anjali Sharma and David Chandler Tags: Research article Source Type: research